Urea 40% Cream

Manufacturer
BioComp Pharma, Inc. | Mission Pharmacal Company
Effective date
2025-12-17
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-05-31 21:51:33

Label at a glance#

ProductUREA
Active ingredientUREA
Label structure12 sections

Dosage and administration

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed. Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

Storage and handling

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. NOTICE: Protect from freezing and excessive heat. Keep bottle tightly closed.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only


FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

DESCRIPTION:

DESCRIPTION SECTION

Each gram contains 400 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, dimethyl isosorbide, glyceryl stearate, mineral oil, petrolatum, propylene glycol, purified water, sodium hydroxide and xanthan gum.


Urea is a diamide of carbonic acid with the following chemical structure:

structure.jpgstructure.jpg

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.


Pharmacokinetics:The mechanism of action of topically applied urea is not yet known.

INDICATIONS:

INDICATIONS & USAGE SECTION

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNING:

WARNINGS SECTION

KEEP OUT OF REACH OF CHILDREN.

PRECAUTIONS:

PRECAUTIONS SECTION

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.


General:This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.


Information for Patients:Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.

Carcinogenesis, Mutagenesis and Impairment of Fertility:Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.


Pregnancy:Category C.Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.


Nursing Mothers:It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.


Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

STORAGE:

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

NOTICE:Protect from freezing and excessive heat. Keep bottle tightly closed.

HOW SUPPLIED:

HOW SUPPLIED SECTION

1 oz. (28.35 g) bottles, NDC44523-617-01
3 oz. (85 g) bottles, NDC44523-617-03
7 oz. (198.4 g) bottles, NDC44523-617-07

To reporta serious adverse event or obtain product information, call 1-866-762-2365.

HOW SUPPLIED:HOW SUPPLIED:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabelLabelLabelLabelLabelCartonCarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
198342urea 40 % Topical CreamPSN6
198342urea 400 MG/ML Topical CreamSCD6
198342urea 40 % Topical CreamSY6

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130344523617070GTIN-13: 0344523617070
EAN-13: 0344523617070
GTIN-12: 344523617070
UPC-A: 344523617070
GTIN storage (14 digits): 00344523617070
7 Oz label.jpg

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
44523-617-01UREA1 in 1 CARTONCREAM16
44523-617-01UREA28.35 g in 1 BOTTLE, PLASTICCREAM28.356
44523-617-03UREA85 g in 1 BOTTLE, PLASTICCREAM856
44523-617-07UREA198.4 g in 1 BOTTLE, PLASTICCREAM198.46

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
44523-617-01GM - Gram44523-61798206e40-aaf9-4816-acf9-a16d3374163f12018-04-19
44523-617-03GM - Gram44523-617a9ec887f-be5a-43af-bbcb-94126b240aed12018-04-19
44523-617-07GM - Gram44523-617fb034714-47f7-40cc-8187-47c508fe0f5d12018-04-19

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
44523-61744523-617-01, 44523-617-03, 44523-617-07

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UREAUREABioComp Pharma, Inc.6774a5ef-9bb0-4e7a-e053-2a91aa0af47f2025-12-17Warnings, Adverse reactionsExact identifier
ndc (package): 44523-617-07
ndc (package): 44523-617-03
ndc (package): 44523-617-01
ndc (product): 44523-617
ndc11 (package): 44523061707
ndc11 (package): 44523061703
ndc11 (package): 44523061701
spl id: 4629c716-aa54-7dc4-e063-6294a90a3dec
spl set id: 6774a5ef-9bb0-4e7a-e053-2a91aa0af47f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.